The Preoperative Treatment of Severely Anemic Patients with a Perfluorochemical Oxygen-Transport Fluid, Fluosol-DA

New England Journal of Medicine

Volumn 307, Issue 5, 1982, Pages 277-283

  Tremper, Kevin K ^a,b,c   Friedman, Alan E ^a,b,c   Levine, Edward M ^a,b,c   Lapin, Ron ^a,b,c   Camarillo, Debra ^a,b,c  

^a UCLA MEDICAL CENTER   (United States)

^b Grifols SA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOSOL DA; PERFLUORODECALIN; PERFLUOROTRIPROPYLAMINE;

ANEMIA; ARTERIAL OXYGEN TENSION; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD SUBSTITUTION; CARDIOVASCULAR SYSTEM; HEART; HEART INDEX; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METHODOLOGY; OXYGEN TRANSPORT; PREOPERATIVE CARE; THERAPY;

EID: 0019992511     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198207293070503     Document Type: Article

References (19)

1. Clark L.C. Jr., Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 1966; 152:1755-1756
2. Geyer R.P., Monroe R.G., Taylor K. Survival of rats having red cells totally replaced with emulsified fluorocarbon. Fed Proc. 1968; 27:384. abstract.
3. Sloviter H.A., Petokovic M., Ogoshi S., Yamada H. Dispersed fluorochemicals as substitutes for erythrocytes in intact animals. J Appl Physiol. 1969; 27:666-668
4. Clark L.C. Jr., Becattini F., Kaplan S. The physiological effects of artificial blood made from inert organic oxygen solvents. Ala J Med Sci. 1972; 9:16-29.
5. Geyer R.P. Fluorocarbon-polyol artificial blood substitutes. N Engl J Med. 1973; 289:1077-1082
6. Gould S.A., Rosen A.L., Sehgal L.R., Sehgal H.L., Rice C.L., Moss G.S. How good are fluorocarbon emulsions as O2 carriers? Surg Forum. 1981; 32:299-301.
7. Ohyanagi H., Toshima K., Sekita M., et al. Clinical studies of perfluorochemical whole blood substitutes: safety of Fluosol-DA(20%) in normal human volunteers. Clin Ther. 1979; 2:306-312
8. Mitsuno T., Ohyanagi H., Naito R. Clinical studies of a perfluorochemical whole blood substitutes (Fluosol-DA). Ann Surg. 1982; 195:60-69
9. Tremper K.K., Lapin R., Levine E., Friedman A., Shoemaker W.C. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, Fluosol-DA (20%). Crit Care Med. 1980; 8:738-741
10. Shoemaker W.C., Appel P.L., Bland R., Hopkins J.A., Chang P. Clinical trial of an algorithm for outcome prediction in acute circulatory failure. Crit Care Med. 1982; 10:390-397
11. Honda K., Hoshino S., Shoji M., et al. Clinical use of blood substitute. N Engl J Med. 1980; 303:391-392
12. Glogar D.H., Kloner R.A., Muller J., DeBoer L.W.V., Braunwald E., Clark L.C. Jr. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science. 1981; 211:1439-1441
13. Peerless S.J., Ishikawa R., Hunter I.G., Peerless M.J. Protective effect of Fluosol-DA in acute cerebral ischemia. Stroke. 1981; 12:558-563
14. Tremper K.K., Shoemaker W.C., Shippy C. Transcutaneous PO2 monitoring of adult patients while hemodynamically stable and during progressive low flow shock. Crit Care Med. 1981; 9:706-709
15. Tremper K.K., Waxman K., Shoemaker W.C. Use of transcutaneous oxygen sensor to titrate PEEP. Ann Surg. 1981; 193:206-209
16. Vercellotti G.M., Hammerschmidt D.E., Jacob H.S., et al. Activation of plasma complement by perfluorocarbon artificial blood, mechanism and prevention of adverse pulmonary reaction. Clin Res. 1981; 29:572A. abstract.
17. Vercellotti G., Hammerschmidt D.E., Craddock P. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis. Blood. 1982; 59:1299-1304
18. Chenoweth D.E., Cooper S.W., Hugh T.E., Stewart R.W., Blackstone E.H., Kirklin J.W. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981; 304:497-503.
19. Craddock P.R., Fehr J., Brigham K.I., Kronenberg R.S., Jacob H.S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977; 296:769-774